CV SCIENCES INC by CV Sciences, Inc. (CVSI) Stock Price, Quote, News & History

Key Statistics

Open

$0.02

Volume / Avg.

629.93K / 586.64K

Day Range

$0.02 - $0.02

52 Wk Range

0.02 - 0.10

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent CV Sciences Inc News

Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know

CV Sciences, Inc. (OTCQB: CVSI) a hemp-focused wellness company announced on Thursday it's acquiring Extract Labs, Inc., a manufacturer and distributor of premium cannabinoid products including gummies, topicals and tinctures. Extract Labs' branded products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C).

Jelena Martinovic

CV Sciences Q3: Revenue Stable Amid New Launches, Financing

CV Sciences Q3 2024 financial results: stable $3.9M revenue, improved 46% gross margin, new products, and nearing cash flow break-even.

Patricio Liddle

Hemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q2

CV Sciences, Inc. (OTCQB: CVSI) a hemp-focused wellness company announced on Tuesday its financial results for the second quarter that ended June 30, 2024, revealing a flat revenue year-over-year at $4 million for the period. "Revenues for our core business remained stable at $4 million in the second quarter of 2024 despite a challenging environment," Joseph Dowling, CEO of CV Sciences, said. "With our recently completed acquisitions and new product innovations, we are planning to grow our revenue in the second half of 2024. Our 47.0% gross margin in the second quarter of 2024 is our best gross margin in the last 13 quarters."

Jelena Martinovic

Hemp-Focused CV Sciences Reports Steady Q1 Revenue Amid Operational Hurdles And Acquisition Of Nutraceuticals Manufacturer

CV Sciences reports a slight Q1 revenue drop and acquires Elevated Softgels, aiming for strategic growth and enhanced production.

Patricio Liddle

Capitalizing On Plant-Based Trend: Cultured Foods Acquisition Allows This US Hemp Co. To Expand In Europe

CV Sciences announced on Tuesday that it has consummated its purchase of Cultured Foods, a leading manufacturer and distributor of alternative plant-based vegan foods. The total consideration for the acquisition of Cultured Foods is up to $535,000.The acquisition creates an opportunity for the importation of Cultured Foods to the US and establishes a European base of operations for the sale and distribution of +PlusCBD products, opening doors to numerous new retail and distributor partners.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-492.00K

Investing Cash Flow (TTM)

-30.00K

Financing Cash Flow (TTM)

-98.00K

Free Cash Flow (TTM)

-522.00K

Capital Expenditure (TTM)

-30.00K

Net Change in Cash (TTM)

-620.00K

Valuation Metrics

Enterprise Value

$5.50M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.30

PB Ratio (TTM)

2.87

Earnings Yield % (TTM)

-100.00%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.01

Company Debt

Total Debt

$1.03M

LT Debt

LT Debt Issuance (TTM)

$450.00K

LT Debt Repayment (TTM)

-$525.00K

Total Cash

$266.00K

Debt to Equity

0.80

Issuance of Debt (TTM)

-$75.00K

Repayment of Debt (TTM)

-$525.00K

Key Statistics

Open

$0.02

Volume / Avg.

629.93K / 586.64K

Day Range

$0.02 - $0.02

52 Wk Range

0.02 - 0.10

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Consumer Staples

Industry

Personal Products

CV Sciences Inc is a consumer wellness company specializing in nutraceuticals and plant-based foods products. It develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The company sells its products under tradenames...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

CVSI

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

CVSI

FAQ

How do I buy CV SCIENCES INC by CV Sciences, Inc. (CVSI) stock?

You can purchase shares of CV SCIENCES INC by CV Sciences, Inc. (OTCQB:CVSI) through any online brokerage.

View our list of the best stock brokerages

Who are CV SCIENCES INC by CV Sciences, Inc. (CVSI) competitors?

There are no as such competitors for CV SCIENCES INC by CV Sciences, Inc..

What is the forecast, or price target, for CV SCIENCES INC by CV Sciences, Inc. (CVSI) stock?

There is no analysis for CV SCIENCES INC by CV Sciences, Inc. to provide a consensus price target.

What is the current price for CV SCIENCES INC by CV Sciences, Inc. (CVSI)?

The stock price for CV SCIENCES INC by CV Sciences, Inc. (OTCQB: CVSI) is $0.019 last updated August 3, 2026 at 4:00 PM EDT.

Does CV SCIENCES INC by CV Sciences, Inc. (CVSI) pay a dividend?

There are no upcoming dividends for CV SCIENCES INC by CV Sciences, Inc..

When is CV SCIENCES INC by CV Sciences, Inc. (OTCQB:CVSI) reporting earnings?

CV SCIENCES INC by CV Sciences, Inc. does not have any upcoming earnings scheduled.

Is CV SCIENCES INC by CV Sciences, Inc. (CVSI) going to split?

There is no upcoming split for CV SCIENCES INC by CV Sciences, Inc..

What sector and industry does CV SCIENCES INC by CV Sciences, Inc. (CVSI) operate in?

CV SCIENCES INC by CV Sciences, Inc. is in the Consumer Staples sector and Personal Products industry. They are listed on the OTCQB.